Regulatory Overview on Past & Present Gamma Delta T Cell Therapies
Time: 1:30 pm
day: Conference Day Two - Track B - PM
Details:
- An overview on the current regulatory landscape for allogeneic therapies and discussing any anticipated changes and trends in the regulatory environment for future allogeneic therapies
- Exploration of potential challenges and opportunities in the evolving regulatory landscape and discussing how to use adaptive strategies to address regulatory uncertainties
